ArticleLeukemia2026

ROR1 upregulation after CD19-CAR T-cell relapse in mantle cell lymphoma identifies a targetable vulnerability for ROR1-directed bispecific modalities.

Yixin Yao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.